Finance

Lists
VERA:NASDAQ
Vera Therapeutics, Inc
$ 26.10
-0.38%
(-0.10) 1D
11-р сарын 18, 10:25:06 (GMT-5)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VERA...
Open
$ 26.11
High
$ 26.54
Low
$ 25.83
Mkt. cap
1.89 тэрбум
Avg. vol.
1.59 сая
Volume
36.62 мян
52-wk high
$ 56.05
52-wk low
$ 25.82
EPS
-$ 5.90
Beta
1.07
Shares outstanding
72.30 сая
No. of employees
362
Open
$ 26.11
High
$ 26.54
Low
$ 25.83
Mkt. cap
1.89 тэрбум
Avg. vol.
1.59 сая
Volume
36.62 мян
52-wk high
$ 56.05
52-wk low
$ 25.82
EPS
-$ 5.90
Beta
1.07
Shares outstanding
72.30 сая
No. of employees
362
News stories
From web sources and news partners
About Vera Therapeutics, Inc
CEO-
Employees362
Founded2016
HeadquartersBrisbane, Калифорни, Америкийн Нэгдсэн Улс
SectorHealth Care
Industry-
Websiteveratx.com
Analyst ratings
Based on 13 analysts giving stock ratings to VERA in the past 3 months
Strong buy
Buy
11
Hold
2
Sell
0
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for VERA in the last 3 months.
Highest
Current $ 26.10
$ 100.00 (+283.14%)
Average
$ 68.82 (+163.68%)
Lowest
$ 29.00 (+11.11%)
Analyst
Recommendation
Action
Price target
Projected
Date
Unknown Analyst
Leerink Partners
Hold
Maintained
$ 35.00
+34.1%
11/17/2026
Anupam Rama
J.P. Morgan
Buy
Maintained
$ 75.00
+187.4%
11/12/2026
Dina Ramadane
Bank of America Securities
Buy
Maintained
-
-
11/06/2026
Laura Chico
Wedbush
Hold
Maintained
$ 29.00
+11.1%
11/06/2026
Pete Stavropoulos
Cantor Fitzgerald
Buy
Maintained
$ 100.00
+283.1%
11/05/2026
Vamil Divan
Guggenheim
Buy
Reiterated
$ 66.00
+152.9%
11/05/2026
Arthur He CFA
H.C. Wainwright
Buy
Reiterated
$ 75.00
+187.4%
11/06/2026
Will Soghikian
Leerink Partners
Hold
Maintained
$ 34.00
+30.3%
10/27/2026
Paul Choi
Goldman Sachs
Buy
Reiterated
$ 80.00
+206.5%
10/22/2026
Mohit Bansal
Wells Fargo
Buy
Maintained
$ 70.00
+168.2%
10/15/2026
Unknown Analyst
Jefferies
Buy
Maintained
$ 59.00
+126.1%
09/16/2026
Rami Katkhuda
LifeSci Capital
Buy
Maintained
$ 90.00
+244.8%
09/15/2026
Ryan Deschner
Raymond James
Buy
Maintained
-
-
09/15/2026
Ritu Baral
TD Cowen
Buy
Maintained
$ 78.00
+198.9%
08/31/2026
Gavin Clark-Gartner
Evercore ISI
Buy
Maintained
$ 91.00
+248.7%
07/09/2026
Unknown Analyst
Wells Fargo
Buy
Maintained
$ 70.00
+168.2%
06/11/2026
Andy Chen
Wolfe Research
Buy
Maintained
$ 88.00
+237.2%
06/02/2026
Unknown Analyst
Wedbush
Hold
Maintained
$ 35.00
+34.1%
05/08/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
2026 оны 9-р сар
Revenue
-
-
-
10.28 сая
Cost of goods sold
-
-
-
3.30 сая
Cost of revenue
-
-
-
3.30 сая
Research and development expenses
59.31 сая
86.01 сая
60.08 сая
41.25 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
34.90 сая
39.12 сая
52.41 сая
61.43 сая
Operating expense
94.21 сая
125.13 сая
112.49 сая
102.68 сая
Total operating expenses
94.21 сая
125.13 сая
112.49 сая
105.98 сая
Operating income
-94.21 сая
-125.13 сая
-112.49 сая
-95.70 сая
Other non operating income
-303.00 мян
-32.00 мян
-483.00 мян
-472.00 мян
EBT including unusual items
-91.10 сая
-121.03 сая
-109.47 сая
-93.71 сая
EBT excluding unusual items
-90.90 сая
-120.63 сая
-109.47 сая
-93.71 сая
Income tax expense
1.00 мян.
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-91.10 сая
-121.03 сая
-109.47 сая
-93.71 сая
Net profit margin
-
-
-
-911.85%
Earnings per share
-1.39
-1.69
-1.52
-1.30
Interest and investment income
5.52 сая
6.36 сая
5.35 сая
4.34 сая
Interest expense
-1.90 сая
-1.82 сая
-1.85 сая
-1.87 сая
Net interest expenses
3.61 сая
4.53 сая
3.50 сая
2.46 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
-94.07 сая
-124.99 сая
-112.36 сая
-94.88 сая
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google аппс